Neurocrine Biosciences, Inc. today announced its financial results for the first quarter ended March 31, 2026. "Neurocrine's ...
Pfizer Inc. (NYSE: PFE) reported financial results for the first quarter of 2026 and reaffirmed its full-year 2026 financial guidance (2).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results